The company organizes scientific and technical personnel and young employees to discuss
Release time:
2020-07-22
Company organized scientific and technical personnel and young employees to have a discussion
News from our newspaper # July 25 . Representatives of scientific and technical personnel and young employees from the Group and its subordinate enterprises participated in the discussion organized by the Group Company respectively. Staff representatives from Yunnan Jianfeng and Daye Jianfeng also participated in the discussion through the video conference system. The leaders of the group company and the heads of relevant departments had face-to-face exchanges with them. At the forum of
, the delegates talked about their feelings and experiences in their work and life, and combined with their own post work, put forward their views and opinions from the aspects of improving the information system, quality management, business learning, assessment and incentive, execution, improving the technical level, hardware facilities, and improving the food in the canteen. The leaders of the company and the heads of relevant departments respectively answered the representative questions raised by the employee representatives, and said that they would sort out and classify these opinions and suggestions, and give them back to the relevant departments and units for improvement and solution. Xiang Chongping, deputy general manager of
group company, said at the forum of scientific and technological personnel that scientific and technological personnel of enterprises are related to the development and growth of enterprises. Therefore, scientific and technological personnel should establish the concept of lifelong learning to adapt to the development and changes of the times, and should be good at learning and improve the efficiency of learning; they should have the courage to take responsibility and have a high sense of responsibility to do a good job, undertake and solve problems; we must dare to innovate. Innovation is the driving force and source of enterprise development. Scientific and technological personnel must be brave to innovate and take the initiative to become indispensable talents for enterprises. At the same time, enterprises must also establish innovation mechanisms and platforms for employees; they must be willing to contribute and do more for the enterprise. contribution. At the youth employee forum of
, Jiang Xiaomeng, chairman of the group company, introduced the current market environment and the basic status quo of the industry from the aspects of cement and medicine, the company's advantages in science and technology, and the problems that need employees' innovative research and careful observation. He hopes that peak employees will take the initiative to find problems, try to solve problems, constantly improve themselves, give full play to their abilities, become indispensable talents for the enterprise, and strive for the future of the enterprise. (Ni yingzhen fangsi)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31